Prognostic value of PLEKHA4 and its correlation with tumor-infiltrating immune cells in breast cancer: a comprehensive study based on bioinformatics and clinical analysis validation
The findings indicate that PLEKHA4 is an independent prognostic biomarker associated with key signaling pathways and immune infiltration in BC. Targeting PLEKHA4 may contribute to improving immunotherapy for BC.
Authors
- Boan Lai
- Zhongtang Xiong (ORCID: https://orcid.org/0000-0003-0175-3138)
- Zhao Ye (ORCID: https://orcid.org/0000-0001-9401-3993)
- Liu Li (ORCID: https://orcid.org/0000-0002-9746-0067)
- Qingxin Zhang (ORCID: https://orcid.org/0009-0003-9178-4612)
- Zewen Feng
- Wei Zhang (ORCID: https://orcid.org/0000-0002-5467-6263)
Institutions
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21037/tcr-24-67
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00